tradingkey.logo

UFP Technologies Inc

UFPT
245.605USD
+11.075+4.72%
Close 11/11, 16:00ETQuotes delayed by 15 min
1.89BMarket Cap
28.22P/E TTM

UFP Technologies Inc

245.605
+11.075+4.72%
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison

TradingKey Stock Score of UFP Technologies Inc

Currency: USD Updated: 2025-11-11

Key Insights

The company's fundamentals are relatively healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. The company is performing strongly in the stock market, with strong fundamentals and technicals supporting the momentum. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

UFP Technologies Inc's Score

Industry at a Glance

Industry Ranking
12 / 209
Overall Ranking
56 / 4608
Industry
Healthcare Equipment & Supplies

Support & Resistance

No Data

Score Analysis

Current score
Previous score

Analyst Rating

Based on 4 analysts
Buy
Current Rating
289.000
Target Price
+23.23%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

UFP Technologies Inc Highlights

StrengthsRisks
UFP Technologies, Inc. is a designer and custom manufacturer of comprehensive solutions for medical devices, sterile packaging, and other engineered custom products. Its single-use and single-patient devices and components are used in a range of medical devices and packaging for minimally invasive surgery, infection prevention, surfaces and support, wound care, wearables, orthopedic soft goods, and orthopedic implants. It is also providing engineered products and components. Typical applications of its products include military uniform and gear components, automotive interior trim, air filtration, and protective cases and inserts. It also engineers’ components for automotive use, such as interior trim and structural applications. These components are produced using a compression molding process. It also develops and manufactures single-use safe patient handling systems, thermoformed, heat-sealed implantable medical device components, custom-engineered foam and thermoplastic components.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 42.58% year-on-year.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 504.42M.
Fairly Valued
The company’s latest PE is 28.16, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 9.09M shares, decreasing 0.46% quarter-over-quarter.
Held by Wasatch Global Investors
Star Investor Wasatch Global Investors holds 650.96K shares of this stock.
Lower Market Activity
The company has less investor interest, with a 20-day turnover ratio of 0.36.

Financial Health

Currency: USD Updated: 2025-11-11

The company's current financial score is 8.88, which is higher than the Healthcare Equipment & Supplies industry's average of 7.46. Its financial status is stable, and its operating efficiency is high. Its latest quarterly revenue reached 154.56M, representing a year-over-year increase of 6.47%, while its net profit experienced a year-over-year increase of 0.13%.

Score

Industry at a Glance

Previous score
8.88
Change
0

Financials

7.52

Key Metrics

Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
No Data

Quality of Earnings

9.11

Operational Efficiency

10.00

Growth Potential

10.00

Shareholder Returns

7.80

UFP Technologies Inc's Company Valuation

Currency: USD Updated: 2025-11-11

The company’s current valuation score is 7.62, which is higher than the Healthcare Equipment & Supplies industry's average of 7.19. Its current P/E ratio is 28.16, which is 96.55% below the recent high of 55.35 and 32.04% above the recent low of 19.14.

Score

Industry at a Glance

Previous score
7.62
Change
0

Valuation Dimensions

P/E
P/B
P/S
P/CF
Industry Ranking 12/209
No Data

Earnings Forecast

Currency: USD Updated: 2025-11-11

The company’s current earnings forecast score is 7.00, which is lower than the Healthcare Equipment & Supplies industry's average of 7.74. The average price target for UFP Technologies Inc is 289.00, with a high of 289.00 and a low of 289.00.

Score

Industry at a Glance

Previous score
7.00
Change
0

Support & Resistance

No Data

Analyst Rating

Based on 4 analysts
Buy
Current Rating
289.000
Target Price
+23.23%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

110
Total
7
Median
9
Average
Company name
Ratings
Analysts
UFP Technologies Inc
UFPT
4
Medtronic PLC
MDT
35
Stryker Corp
SYK
33
Abbott Laboratories
ABT
32
Dexcom Inc
DXCM
30
Zimmer Biomet Holdings Inc
ZBH
30
1
2
3
...
22

Financial Forecasting

EPS
Revenue
Net Profit
EBIT
No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-11-11

The company’s current price momentum score is 9.35, which is higher than the Healthcare Equipment & Supplies industry's average of 7.18. Sideways: Currently, the stock price is trading between the resistance level at 278.78 and the support level at 197.65, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score
9.07
Change
0.28

Support & Resistance

No Data

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators
Sell(1)
Neutral(0)
Buy(6)
Indicators
Value
Direction
MACD(12,26,9)
10.076
Buy
RSI(14)
70.878
Buy
STOCH(KDJ)(9,3,3)
67.757
Buy
ATR(14)
14.068
High Vlolatility
CCI(14)
121.283
Buy
Williams %R
22.672
Buy
TRIX(12,20)
0.507
Sell
StochRSI(14)
94.658
Buy
Moving Average
Sell(0)
Neutral(0)
Buy(6)
Indicators
Value
Direction
MA5
232.701
Buy
MA10
215.289
Buy
MA20
207.056
Buy
MA50
202.282
Buy
MA100
216.381
Buy
MA200
222.761
Buy

Institutional Confidence

Currency: USD Updated: 2025-11-11

The company’s current institutional recognition score is 10.00, which is higher than the Healthcare Equipment & Supplies industry's average of 6.43. The latest institutional shareholding proportion is 117.95%, representing a quarter-over-quarter increase of 0.73%. The largest institutional shareholder is Wasatch Global Investors, holding a total of 650.96K shares, representing 8.44% of shares outstanding, with 12.32% increase in holdings.

Score

Industry at a Glance

Previous score
10.00
Change
0

Institutional Shareholding

No Data

Shareholder Activity

Name
Shares Held
Chg %
BlackRock Institutional Trust Company, N.A.
990.61K
-1.85%
Wasatch Global Investors Inc
Star Investors
650.96K
+1.37%
The Vanguard Group, Inc.
Star Investors
522.31K
+0.36%
Neuberger Berman, LLC
335.93K
-2.70%
Congress Asset Management Company, LLP
327.43K
+5.83%
American Century Investment Management, Inc.
325.05K
+13.03%
State Street Investment Management (US)
283.32K
-0.02%
Boston Trust Walden Company
255.38K
+19.25%
Renaissance Technologies LLC
Star Investors
233.26K
-10.17%
Geode Capital Management, L.L.C.
186.09K
+3.28%
1
2

Risk Assessment

Currency: USD Updated: 2025-11-11

The company’s current risk assessment score is 6.67, which is higher than the Healthcare Equipment & Supplies industry's average of 4.58. The company's beta value is 1.06. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.

Score

Industry at a Glance

Previous score
6.67
Change
0
Beta vs S&P 500 index
1.06
VaR
+4.07%
240-Day Maximum Drawdown
+42.62%
240-Day Volatility
+56.36%

Return

Best Daily Return
60 days
+12.05%
120 days
+12.05%
5 years
+18.59%
Worst Daily Return
60 days
-5.00%
120 days
-11.28%
5 years
-12.35%
Sharpe Ratio
60 days
+1.28
120 days
+0.34
5 years
+1.01

Risk Assessment

Maximum Drawdown
240 days
+42.62%
3 years
+48.31%
5 years
+48.31%
Return-to-Drawdown Ratio
240 days
-0.51
3 years
+0.82
5 years
+1.76
Skewness
240 days
+0.11
3 years
+0.35
5 years
+0.41

Volatility

Realised Volatility
240 days
+56.36%
5 years
+45.15%
Standardised True Range
240 days
+4.51%
5 years
+2.62%
Downside Risk-Adjusted Return
120 days
+53.34%
240 days
+53.34%
Maximum Daily Upside Volatility
60 days
+68.20%
Maximum Daily Downside Volatility
60 days
+26.29%

Liquidity

Average Turnover Rate
60 days
+1.88%
120 days
+1.87%
5 years
--
Turnover Deviation
20 days
+36.18%
60 days
+63.25%
120 days
+61.95%

Peer Comparison

Healthcare Equipment & Supplies
UFP Technologies Inc
UFP Technologies Inc
UFPT
8.30 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Castle Biosciences Inc
Castle Biosciences Inc
CSTL
8.68 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Cencora Inc
Cencora Inc
COR
8.64 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
TCMD
8.61 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
AxoGen Inc
AxoGen Inc
AXGN
8.55 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
STERIS plc
STERIS plc
STE
8.53 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
KeyAI